Drug Trial Radar · NCT07441642
A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
272
Planned (sponsor's estimate)
Start
Mar 9, 2026
Primary completion
Aug 21, 2029
Study completion Aug 22, 2029
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Mar 2, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To characterize the dose response relationship of FWY003 in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD).
Conditions
- Geographic Atrophy Secondary to Age-related Macular Degeneration
Interventions
FWY003Drug
FWY003 arm participants will receive a specific dose of FWY003
PlaceboDrug
Placebo arm participants will receive placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change of geographic atrophy (GA) lesion area in the study eyeTime frame: From Baseline to Month 18
Locations
65 sites in 19 countries. Site status is shown where the registry gives one.
Salehi Retina Institute
Huntington Beach, California · Recruiting
Retinal Consultants Medical Group Inc
Sacramento, California · Recruiting
California Retina Consultants
Santa Barbara, California · Recruiting
Advanced Research LLC
Boynton Beach, Florida · Recruiting
Advanced Research LLC
Deerfield Beach, Florida · Recruiting
Retina Vitreous Associates of Florida
St. Petersburg, Florida · Recruiting
Retina Associates New Orleans
Metairie, Louisiana · Recruiting
Opthamalic Consultants of Boston
Boston, Massachusetts · Recruiting
NJ Retina
Toms River, New Jersey · Recruiting
New York Eye and Ear Infirmary of Mount Sinai
New York, New York · Recruiting
Columbia University Medical Center
New York, New York · Recruiting
Erie Retina Research LLC
Erie, Pennsylvania · Recruiting
Mid Atlantic Retina
Philadelphia, Pennsylvania · Recruiting
Retina Consultants TX Rsrch Ctr
Bellaire, Texas · Recruiting
Retina Consultants of Houston PA
Houston, Texas · Recruiting
Retina Consultants of Texas
Katy, Texas · Recruiting
Novartis Investigative Site
Caba, Argentina · Recruiting
Novartis Investigative Site
CABA, Argentina · Recruiting
Novartis Investigative Site
Rosario, De Santa Fe, Argentina · Recruiting
Novartis Investigative Site
Albury, New South Wales, Australia · Recruiting
Novartis Investigative Site
Parramatta, New South Wales, Australia · Recruiting
Novartis Investigative Site
Strathfield, New South Wales, Australia · Recruiting
Novartis Investigative Site
East Melbourne, Victoria, Australia · Recruiting
Novartis Investigative Site
Serra, Espírito Santo, Brazil · Recruiting
Novartis Investigative Site
Blumenau, Santa Catarina, Brazil · Recruiting
Novartis Investigative Site
Sofia, Bulgaria · Recruiting
Novartis Investigative Site
London, Ontario, Canada · Recruiting
Novartis Investigative Site
Ottawa, Ontario, Canada · Recruiting
Novartis Investigative Site
Shanghai, China · Recruiting
Novartis Investigative Site
Medellín, Antioquia, Colombia · Recruiting
Novartis Investigative Site
Barranquilla, Atlántico, Colombia · Recruiting
Novartis Investigative Site
Prague, Czechia · Recruiting
Novartis Investigative Site
Prague, Czechia · Recruiting
Novartis Investigative Site
Créteil, France · Recruiting
Novartis Investigative Site
Dijon, France · Recruiting
Novartis Investigative Site
Paris, France · Recruiting
Novartis Investigative Site
Lyon, Rhone, France · Recruiting
Novartis Investigative Site
Bonn, Germany · Recruiting
Novartis Investigative Site
Münster, Germany · Recruiting
Novartis Investigative Site
Tübingen, Germany · Recruiting
Showing 40 of 65 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.